Submit Your Feeds

Business News • PR NewsWire • Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias

Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias

ORLANDO, Fla., Dec. 4, 2010 /PRNewswire-USNewswire/ -- Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of

View More : http://www.prnewswire.com/news-releases/breakthrough-therapies-and-a-new-gene-target-advance-the-treatment-and-understan...
Releted News by prnewswire
Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
The LEGO® Store Grand Re-Opening at Mall of America®
Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
VIDEO from International Institute for Strategic Studies Available on thenewsmarket.com: Foreign Affairs Ministers Talk About Conflicts and Outside Powers at Manama Dialogue
Third Annual Game Developers Conference™ China Opens for Three Days of Learning, Inspiration and Networking
National League of Cities Elects Charlotte Council Member James E. Mitchell Jr., as President
Home Sitemap Contact Us
© businessNewsNewsNews.com